Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Vevo Therapeutics
company
About
Vevo Therapeutics that is combining in vivo data generated at scale with AI to find better targets and drugs to treat more patients.
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $12M
- Industries
- Artificial Intelligence,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2022
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12M
Vevo Therapeutics has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2022 | Seed | $12M | 1 |
General Catalyst
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Vevo Therapeutics is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
General Catalyst
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
